Cargando…
Cost-effectiveness evaluation of glucosamine for osteoarthritis based on simulation of individual patient data obtained from aggregated data in published studies
BACKGROUND: The economic evaluation of treatments usually requires access to individual patient data, which is difficult to obtain. Moreover, in osteoarthritis, health utility scores are unavailable and can be assessed only using a validated equation model based on various clinical data. We aimed to...
Autores principales: | Bruyère, Olivier, Reginster, Jean-Yves, Honvo, Germain, Detilleux, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583676/ https://www.ncbi.nlm.nih.gov/pubmed/30746645 http://dx.doi.org/10.1007/s40520-019-01138-1 |
Ejemplares similares
-
Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand
por: Bruyère, Olivier, et al.
Publicado: (2023) -
Glucosamine sulphate: an umbrella review of health outcomes
por: Veronese, Nicola, et al.
Publicado: (2020) -
Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019) -
Role of glucosamine in the treatment for osteoarthritis
por: Reginster, Jean-Yves, et al.
Publicado: (2012) -
Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
por: Bruyère, Olivier, et al.
Publicado: (2022)